An important role for VCAM-1, but not for ICAM-1 in restenosis following coronary stent implantation;Koroner stent implantasyonu sonrası restenozda ICAM-1'e göre VCAM-1'in önemli rölü

Anadolu Kardiyoloji Dergisi

Volumn 10, Issue 5, 2010, Pages 405-409

  Bayata, Serdar ^a   Arikan, Erdinç ^a   Yeşil, Murat ^a   Postaci, Nursen ^a   Taş, Abdülaziz ^a   Köseoǧlu, Mehmet ^a  

^a Ataturk Teaching Hospital   (Turkey)

Author keywords

Inflammation; Intercellular adhesion molecule 1; Restenosis; Stenting; Vascular cell adhesion molecule 1

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY ARTERY PRESSURE; CORONARY STENT; DISEASE MARKER; FEMALE; HUMAN; IN-STENT RESTENOSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LOADING DRUG DOSE; MALE; OBSERVATIONAL STUDY; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL PARAMETERS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; STABLE ANGINA PECTORIS; STENT THROMBOSIS; SURGICAL APPROACH;

EID: 78049365479     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2010.137     Document Type: Article

References (28)

1. Hermans WR, Rensing BJ, Foley DP, Tijssen JG, Rutsch W, Emanuelsson H, et al. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. J Cardiovasc Pharmacol 1993; 22: 45-57.
2. Melkert R, Violaris AG, Serruys PW. Luminal narrowing after percutaneous transluminal coronary angioplasty: a multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin. J Invasive Cardiol 1994; 6: 160-71.
3. Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53: 77-81.
4. Weintraub WS, Kosinski AS, Brown CL 3rd. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol 1993; 21: 6-14.
5. Hermans WR, Foley DP, Rensing BJ, Rutsch W, Heyndrickx GR, Danchin N, et al. Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. CARPORT and MERCATOR Study Groups. Am J Cardiol 1993; 72: 14-20.
6. Hirshfeld JW Jr, Schwartz JS, Jugo R, MacDonald RG, Goldberg S, Savage MP, et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. The M-HEART Investigators. J Am Coll Cardiol 1991; 18: 647-56.
7. Mercado N, Boersma E, Wijns W, Gersh BJ, Morillo CA, De Valk V, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001; 38: 645-52.
8. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998; 18: 842-51.
9. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin İnvest 1993; 92: 945-51.
10. Danenberg HD, Welt FG, Walker M 3rd, Seifert P, Toegel GS, Edelman ER. Systemic inflammation induced by lipopolysaccharide increases neointimal formation after balloon and stent injury in rabbits. Circulation 2002; 105: 2917-22.
11. Pietersma A, Kofflard M, De Wit LE, Stijnen T, Koster JF, Serruys PW, et al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995; 91: 1320-5.
12. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schächinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 2001; 37: 839-46.
13. Gottsauner-Wolf M, Zasmeta G, Hornykewycz S, Nikfardjam M, Stepan E, Wexberg P, et al. Plasma levels of C-reactive protein after coronary stent implantation. Eur Heart J 2000; 21:1152-8.
14. Almagor M, Keren A, Banai S. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. Am Heart J 2003; 145: 248-53.
15. Fukuda D, Shimada K, Tanaka A, Kawarabayashi T, Yoshiyama M, Yoshikawa J. Circulating monocytes and in-stent neointima after coronary stent implantation. J Am Coll Cardiol 2004; 43: 18-23.
16. Hokimoto S, Ogawa H, Saito T, Oshima S, Noda K, Soejima H, et al. Increased plasma antigen levels of monocyte chemoattractant protein-1 in patients with restenosis after percutaneous transluminal coronary angioplasty. Jpn Circ J 2000; 64: 831-4.
17. Rogers C, Welt FG, Karnovsky MJ, Edelman ER. Monocyte recruitment and neointimal hyperplasia in rabbits. Coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol 1996; 16: 1312-8.
18. Moreno PR, Bernardi VH, Lopez-Cuellar J, Newell JB, McMellon C, Gold HK, et al. Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina. Circulation 1999; 94: 3098-102.
19. Manka DR, Wiegman P, Din S, Sanders JM, Green SA, Gimple LW, et al. Arterial injury increases expression of inflammatory adhesion molecules in the carotid arteries of apolipoprotein-E-deficient mice. J Vasc Res 1999; 36: 372-8.
20. Oguchi S, Dimayuga P, Zhu J, Chyu KY, Yano J, Shah PK, et al. Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. ArteriosclerThromb Vasc Biol 2000; 20: 1729-36.
21. Wang YJ, Wang JT, Fan QX, Geng JG. Andrographolide inhibits NF-KB activation and attenuates neointimal hyperplasia in arterial restenosis. Cell Res 2007; 17: 933-41.
22. Inoue T, Hoshi K, Yaguchi I, Iwasaki Y, Takayanagi K, Morooka S. Serum levels of circulating adhesion molecules after coronary angioplasty. Cardiology 1999; 91: 236-42.
23. Tsakiris DA, Circulating cell adhesion molecules and endothelial markers before and after angioplasty in peripheral arterial occlusive disease. Atherosclerosis 1999; 142: 193-200.
24. Shillinger M, Exner M, Mlekusch W, Haumer M, Ahmadi R, Rumpold H, et al. Inflamatory response to stent implantation: differences in femoro-popliteal, iliac, and carotid arteries. Radiology 2002; 224: 529-35.
25. Heider P, Wildgruber MG, Weiss W, Berger HJ, Eckstein HH, Wolf O. Role of adhesion molecules in the induction of restenosis after angioplasty in the lower limb. J Vasc Surg 2006; 43: 969-77.
26. Kamijikkoku S, Murohara T, Tayama S, Matsuyama K, Honda T, Ando M, et al. Acute myocardial infarction and increased soluble intercellular adhesion molecule-1: a marker of vascular inflammation and a risk of early restenosis. Am Heart J 1998; 136: 231-6.
27. Karabela G, Adamopoulos S, Karavolias G, Haidaroglou A, Degiannis D, Voudris V, et al. Immuno-inflammatory cascade activation and restenosis in stable and unstable angina patients undergoing coronary interventions. Circulation 2008; 118: S805-S806. (Abstract 3037)
28. Hagemeyer CE, Ahrens I, Bassler N, Dschachutaschwill N, Chen YC, Eisenhardt SU, et al. Genetic transfer of fusion proteins effectively inhibits VCAM-1 mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage. J Cell Mol Med 2010; 14: 290-302.